News-News-LYZZ Capital

News

2026.03.16 In Vivo Podcast: Onchilles Pharma’s Neutrophil-Derived Path To Pan-Cancer Therapy: 2026.03.16
In Vivo Podcast: Onchilles Pharma’s Neutrophil-Derived Path To Pan-Cancer Therapy
view more

2026.02.24 Onchilles Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Confere...: 2026.02.24
Onchilles Pharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Confere...
view more

2026.02.03 Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation...: 2026.02.03
Onchilles Pharma Announces IND Clearance for N17350, Advancing the First Next-Generation...
view more

2026.01.22 U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatm...: 2026.01.22
U.S. FDA Grants to Wugen’s WU-CART-007 Breakthrough Therapy Designation for Treatm...
view more

2025.12.08 Wugen to Present Correlative Data and Long-Term Follow-Up Updates for Off-the-Shelf, All...: 2025.12.08
Wugen to Present Correlative Data and Long-Term Follow-Up Updates for Off-the-Shelf, All...
view more

2025.11.08 Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the...: 2025.11.08
Onchilles Pharma Publishes Landmark ELANE Pathway Study and Advances N17350 Toward the...
view more

1
2
3
4
5
6
7
8
...
13
14